The 32nd European Congress on Obesity ends today so there are various news articles. I find the reporting on obesity frustrating, as they never link to the actual research studies and/or they are behind paywalls.
The comments on the Telegraph article show that naturally thin people think we are lazy, ill disciplined and simply need to eat less and move. They have no idea.
When writing about the risks of WLI, journalists don't weigh those risks against the positive benefits of weight loss. Things like not dying early and the illnesses and medical events related to being so fat we won't experience if we shed the weight. They don't understand the compulsion and helplessness of women like us who have repeatedly failed to shed and keep weight off, the desperation and sadness.
Data from the Select trial (conducted by semaglutide manufacturer Novo Nordisk om 5 years of data on 17,604 adults over the age of 45 from 41 countries) found that Wegovy/Ozempic injections halved the risk of heart attack deaths after six months - even for those who don't lose much weight. Cardiologist and UCL professor, Prof John Deanfield, a government adviser on health policy, said it's a gamechanger. “Around half of the patients that I see in my cardiovascular practice have levels of weight equivalent to those in the Select trial and are likely to derive benefit from taking semaglutide on top of their usual level of guideline-directed care."
“Our findings show that the magnitude of this treatment effect with semaglutide is independent of the amount of weight lost, suggesting that the drug has other actions which lower cardiovascular risk beyond reducing unhealthy body fat.
“These alternative mechanisms may include positive impacts on blood sugar, blood pressure or inflammation, as well as direct effects on the heart muscle and blood vessels, or a combination of one or more of these."
Professor Donna Ryan, of Pennington Biomedical Research Centre, found weight loss using semaglutide “can be sustained for up to four years” in adults who are overweight or obese, without diabetes. The Independent reported more than the Telegraph and ITV etc www.independent.co.uk/news/health/ozempic-weight-loss-jab-heart-attack-stroke-b2544452.html